Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype

scientific article published on 23 May 2016

Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SREP26345
P932PMC publication ID4876328
P698PubMed publication ID27211104

P50authorFrancesco MarincolaQ107723823
P2093author name stringHui Liu
Davide Bedognetti
Ena Wang
David Stroncek
Ping Jin
Jiaqiang Ren
Jinguo Chen
Shutong Liu
Yuanlong Zhao
Jianjian Jin
P2860cites workPredictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.Q50954469
An immune-active tumor microenvironment favors clinical response to ipilimumabQ56898024
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cellsQ61645531
Combination Immunotherapy for MelanomaQ85609445
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor MicroenvironmentQ26796305
The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signaturesQ27015137
Multilineage potential of adult human mesenchymal stem cellsQ27860737
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patientsQ29617771
Marrow stromal cells as stem cells for nonhematopoietic tissuesQ29618770
PD-1 blockade induces responses by inhibiting adaptive immune resistanceQ29620856
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trialQ30407940
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitmentQ30415355
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaQ30423599
Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programmeQ33750137
TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trialQ35105819
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesisQ35541507
Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potencyQ36076501
Gene-expression profiling in vaccine therapy and immunotherapy for cancerQ36138329
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genesQ36419244
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.Q36456711
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.Q37279217
Mechanisms of mesenchymal stromal cell immunomodulationQ38054535
Prognostic and predictive immune gene signatures in breast cancer.Q38595111
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patientsQ38890435
Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cellsQ42581359
Prediction of response to anticancer immunotherapy using gene signaturesQ44721413
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)26345
P577publication date2016-05-23
P1433published inScientific ReportsQ2261792
P1476titleInterferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype
P478volume6

Reverse relations

cites work (P2860)
Q42376411Calreticulin is an effective immunologic adjuvant to tumor-associated antigens
Q91425930Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated
Q39458079Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia/reperfusion-induced acute lung injury in rats
Q49905713IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate.
Q37522385Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii
Q47171983Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration
Q42030296Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype
Q60046871Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
Q91792198Mesenchymal stem cell perspective: cell biology to clinical progress
Q28078893Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response
Q90432906Pro-Inflammatory Priming of Umbilical Cord Mesenchymal Stromal Cells Alters the Protein Cargo of Their Extracellular Vesicles
Q40594698Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation
Q42051201Quantifiable Metrics for Predicting MSC Therapeutic Efficacy
Q42373856Response of human periodontal ligament stem cells to IFN-γ and TLR-agonists
Q33732986Revisiting the hallmarks of cancer
Q58569274Sequential modes of crosslinking tune viscoelasticity of cell-instructive hydrogels
Q40114819Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
Q58130125Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab
Q60911874Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture
Q42645831Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells.
Q57463397Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury
Q38749247Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis
Q90677434TGF-β-responsive CAR-T cells promote anti-tumor immune function
Q96342890TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo
Q58697292Tenogenic Properties of Mesenchymal Progenitor Cells Are Compromised in an Inflammatory Environment
Q99564846The influenza virus NS1A binding protein gene modulates macrophages response to cytokines and phagocytic potential in inflammation

Search more.